GOSS.OQ - Gossamer Bio Inc
Guggenheim Securities LLCEstimate Increase
GOSS: Discussion With Management Provides Added Insights Into Path Forward for Seralutinib; Challenges Remain, But Management Remains Confident
公司
GOSS.OQ
日期
2026-02-23
分析师
Mr. Vamil K. Divan, MD
页数
8 页
需要登录
请登录后购买研报或生成音频内容。